Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by bloomfield18

T.IVN

RE:RE:RE:RE:RE:RE:RE:RE:IVN value tied to Kakula

Allen, You're right. It's an updated PEA, not a PFS. Thanks for the...

May 21, 2017

T.IVN

New Congo Mining Law

http://www.mining.com/congo-re-evaluate-new-mining-code-next-week/

May 21, 2017

T.IVN

RE:RE:RE:RE:RE:RE:IVN value tied to Kakula

With the 2017 Prefeasibility you no longer have to refer to the PEA study. A...

May 21, 2017

T.IVN

RE:RE:RE:RE:RE:RE:IVN value tied to Kakula

JB, I use NPV, net present value, because that's what investment bankers...

May 21, 2017

T.IVN

RE:RE:RE:RE:IVN value tied to Kakula

These are not my numbers. They all come from the prefeasibility study of Jan...

May 21, 2017

T.IVN

RE:RE:IVN value tied to Kakula

Mr. Bigger, Please refer to the Jan 27, 2017 PEA study. Go to economic...

May 20, 2017

T.IVN

RE:RE:IVN value tied to Kakula

Johnny, Robert Friedland is not making wild promises of $20 to $30 a share...

May 20, 2017

T.IVN

IVN value tied to Kakula

Plareef failed to show much NPV. Kipushi shows NPV of about a billion dollars...

May 20, 2017

T.IVN

RE:RE:RE:A respected analyst's opinion of IVN's true economic value

Allen,  Thanks for the correction. Canadian Mining Journal has it as...

May 20, 2017

T.IVN

RE:A respected analyst's opinion of IVN's true economic value

JB, There are over 786 million shares out. If IVN were to go to $30 a share,...

May 20, 2017

T.IVN

RE:RE:Re: Kukula West?

I was trained as a geologist. But what you are describing is a legal matter...

May 20, 2017

T.IVN

Re: Kukula West?

$20 a share is wildly optimistic at this point. $10 maybe. We're talking...

May 20, 2017

T.IVN

Kakula West?

Most of the NPV (Net Present Value) for IVN is tied up with Kukula. The zinc...

May 19, 2017

T.IVN

RE:RE:Just sit and soak this in

More like sit back and take a beating. I agree IVN is a great play, but that...

May 4, 2017

T.IVN

RE:So are we going to go any lower...

It will be trading up and down. Traders will love it. Right now the trend for...

May 4, 2017

T.IVN

Sell in May and go away

I've seen this movie too many times already. Metal commodities are...

May 4, 2017

T.FCU

Excellent Posts

A lot of knowledgable investors on the FCU and NXE boards.

April 2, 2017

T.IVN

RE:You guys crack me up

We're not crackhead lemmings. We're just lemmings.

April 2, 2017

T.IVN

RE:Where is the new money going to come from ?

The company had $365 million in working capital as of Jan 1. They don't...

March 28, 2017

T.IVN

RE:RE:RE:Very little retail buying atm....

On the other hand, there are people fishing for shares. For those...

March 24, 2017

Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next

Featured Company

BioVaxys Technology Corp.

BioVaxys Technology Corp. C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ... view more »